Biotechnology company ATAI Life Sciences plans to purchase $5 million worth of BTC

BlockBeats News: On March 21st, biopharmaceutical company ATAI Life Sciences announced that it will adopt a Bitcoin financial strategy and plans to invest an initial $5 million to purchase Bitcoin. Affected by this news, ATAI's stock price briefly rose. The chairman of the company, Christian Angermayer, stated that the company's initial plan is to invest $5 million to purchase Bitcoin, while retaining sufficient cash, short-term securities, and public equity to safeguard the company's operating funds until 2027.